Armata Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.28
|
-0.24
|
0.04
|
14.29%
|
|
2022-06-30
|
-0.23
|
-0.26
|
-0.03
|
-13.04%
|
|
2022-03-31
|
-0.21
|
-0.30
|
-0.09
|
-42.86%
|
|
2021-12-31
|
-0.28
|
-0.23
|
0.05
|
17.86%
|
|
2021-09-30
|
-0.26
|
-0.22
|
0.04
|
15.38%
|
|
2021-06-30
|
-0.26
|
-0.25
|
0.01
|
3.85%
|
|
2021-03-31
|
-0.32
|
-0.27
|
0.05
|
15.63%
|
|
2020-12-31
|
-0.29
|
-0.36
|
-0.07
|
-24.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.80
|
|
2021-12-31
|
-0.97
|
|
2020-12-31
|
-1.42
|
|
2019-12-31
|
-3.31
|
|
2018-12-31
|
-9.52
|
|
2017-12-31
|
-33.13
|
|
2016-12-31
|
-18.67
|
|
2015-12-31
|
-888.62
|
|
2007-12-31
|
-7140.00
|
|
2006-12-31
|
-24426.51
|
|
2005-12-31
|
-15400.00
|
|
2004-12-31
|
-12600.00
|
|
2003-12-31
|
-17948.65
|
|
2002-12-31
|
-36701.87
|
|
2001-12-31
|
-42000.00
|
|
2000-12-31
|
-75649.87
|
|
1998-12-31
|
-50958.69
|
|
1996-12-31
|
-42700.00
|
|
1995-12-31
|
-45500.00
|
|
1994-12-31
|
-35000.00
|